Skip to main content
MBI logo

MBI — Investor Relations & Filings

Ticker · 1783 ISIN · TW0001783009 TW Manufacturing
Filings indexed 1,694 across all filing types
Latest filing 2024-05-06 Director's Dealing
Country TW Taiwan
Listing TW 1783

About MBI

www.mbi.com.tw

Maxigen Biotech Inc. (MBI) is a medical device manufacturer specializing in the research, development, and production of biopolymer-based solutions, primarily focusing on collagen matrix and hyaluronic acid technologies. The company provides a comprehensive range of medical devices across multiple clinical disciplines, including orthopedics, aesthetics, ophthalmology, and wound care. Key products include hyaluronic acid intra-articular injections, dermal fillers, ophthalmic viscoelastics, collagen wound dressings, dental membranes, and synthetic bone grafts. In addition to its proprietary brands, MBI offers global OEM/ODM and customization services. The company adheres to international quality standards, holding certifications such as CE, FDA, NMPA, and MDSAP. MBI leverages its expertise in biopolymer science to deliver innovative medical and skincare products to international markets.

Recent filings

Filing Released Lang Actions
113年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabular disclosure of shareholdings by insiders, including directors, supervisors, and senior management, showing their current holdings, pledged shares, and related information. It is focused on insider shareholdings and does not contain financial statements, earnings data, or management discussion. The content matches the description of a Director's Dealing or insider share transaction report, as it reports personal share transactions or holdings by company directors and executives. The document length is about 3,000 characters, which is consistent with a detailed insider shareholding report rather than a full financial report or announcement. Therefore, the most appropriate classification is Director's Dealing (DIRS).
2024-05-06 Chinese
113年第1季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for the first quarter of the fiscal year 2024 (民國113年第1季) and the same period last year. It includes line items such as common stock, capital surplus, retained earnings, and other equity components. The presence of actual financial data for a quarterly period indicates this is a substantive financial report for a period shorter than a full fiscal year. The document length is 3437 characters, which is sufficient to contain meaningful financial data rather than just an announcement. There is no indication that this is an announcement or a certification. Therefore, the document is best classified as an Interim / Quarterly Report (IR). Q1 2024
2024-05-03 Chinese
113年第1季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the first quarter of the fiscal year 113 (which corresponds to 2024 in the Taiwanese calendar). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 2051 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-05-03 Chinese
113年第1季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the first quarter of the 113th year (which corresponds to 2024) with detailed financial figures such as revenue, costs, expenses, and earnings per share. The presence of actual financial data for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 2177 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-05-03 Chinese
113年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates such as March 31, 2024 (民國113年第1季), December 31, 2023, and March 31, 2023. It includes comprehensive financial statement line items such as current assets, non-current assets, liabilities, equity, and detailed breakdowns of each. The presence of actual financial figures and the nature of the data indicate this is a financial report rather than an announcement or summary. The document length is 4479 characters, which is relatively short but contains substantive financial data. Given the quarterly dates and the detailed financial statements, this aligns with an Interim / Quarterly Report (IR) rather than a full Annual Report (10-K) or just an earnings release (ER). There is no indication that this is a mere announcement or certification, so it is not RPA or RNS. Therefore, the best classification is Interim / Quarterly Report (IR). Q1 2024
2024-05-03 Chinese
董事會決議股利分派
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement (768 characters) from a company (1783 和康生) regarding a board resolution on dividend distribution for the fiscal year 112 (2023). It specifies cash dividend per share, total cash dividend amount, and other dividend-related details. There is no detailed financial data or comprehensive report content, only a summary of dividend decisions. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2024-05-03 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.